Breaking News, Promotions & Moves

Korsana Biosciences Taps Dr. Mark Vignola as CFO

Vignola brings extensive leadership experience in corporate finance across the biotech industry.

Author Image

By: Charlie Sternberg

Associate Editor

Korsana Biosciences Inc., a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, has welcomed Mark Vignola, Ph.D., as its new Chief Financial Officer (CFO). “We are excited to welcome Mark as our Chief Financial Officer, with his extensive experience as a strategic financial leader to biotech companies and strong track record of advancing companies through major inflection points,” said Jonathan Violin, Ph.D., President and CEO o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters